statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Neuropathix is a biopharmaceutical company focused on the research and development of next generation, breakthrough anti-inflammatory therapeutics. The company's subsidiary Kannalife Sciences developed their lead compound, KLS-13019 which has been extensively researched in preclinical and IND-enabling studies and found to be effective in the prevention and reversal of peripheral neuropathy. Kannalife’s research has been backed by a total of $3.3 million in grant funding from the National Institutes of Health (NIH) under the NIH HEAL Initiative and focused on the treatment of chemotherapy induced peripheral neuropathy (CIPN). KLS-13019 is part of a globally patented estate of new therapeutic synthetic cannabinoids designed by Kannalife, focused on neuroprotection and neuroinflammation. The company conducts its research and development efforts at the Pennsylvania Biotechnology Center of Bucks County in Doylestown, PA.

Neuropathix Inc

Volume	64,364.00
52-Wk High	$0.0154
52-Wk Low	$0.0002

NPTX Neuropathix Inc

About

Feed

News

Fundamentals